SCHEMBL5080265

SCHEMBL5080265

Cc1cc(-c2cccs2)nc2cc(Nc3nccn4c(C5CCC5)ncc34)ccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
PRKDC P78527 1/20 0.34
SRC P12931 1/20 0.33
PDGFRB P09619 1/20 0.33
KIT P10721 1/20 0.33
FLT3 P36888 1/20 0.33
TNK2 Q07912 2/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
CYP3A4 P08684 2/20 0.32
IGF1R P08069 1/20 0.32
MCHR1 Q99705 1/20 0.32
FGFR1 P11362 2/20 0.31
PTK6 Q13882 1/20 0.31
GAA P10253 4/20 0.31
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPT P10636 3/20 0.31
POLB P06746 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5082157 0.89 IGF1R (0.38) RAB9ANPC1PRKDCSRCPDGFRB
SCHEMBL5083550 0.88 IGF1R (0.40) RAB9ANPC1PDGFRBKITFLT3
SCHEMBL5082928 0.86 IGF1R (0.40) TNK2CYP3A4IGF1RMAPK1
SCHEMBL5086159 0.86 TNK2 (0.35) TNK2CYP3A4IGF1RGAAKDM4E
SCHEMBL5082839 0.79 TNK2 (0.41) TNK2KDM4EALDH1A1HPGD
SCHEMBL5083767 0.78 IGF1R (0.46) RAB9ANPC1SRCPDGFRBKIT
SCHEMBL5084929 0.77 IGF1R (0.47) RAB9ANPC1FLT3TNK2CYP3A4
SCHEMBL5083969 0.75 IGF1R (0.46) TNK2CYP3A4IGF1RMAPK1
SCHEMBL5081943 0.73 IGF1R (0.35) KITCYP3A4IGF1RKDM4EMAPT
SCHEMBL401395 0.73 IGF1R (0.62) TNK2CYP3A4IGF1RFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008076143-A1 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2008-06-26 WO disclosed